The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 25%.
Diversified Healthcare Trust - DHCNI
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $18.14
Diversified Healthcare Trust - holds its Markdown at $18.14.
- PHPhase · the trend structure carries the Markdown label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · screen not yet scored
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markdown · caution |
| Quantitative state | Elevated stress, defensive posture warranted, held for 63 days |
| Price | $18.14 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | N/A |
Where & how to trade · wherever in the world you are
DHCNI trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 23%. Our forward projection puts the odds of a 10% gain over the next month near 25%.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $18.59 | -2.8% | · | $972 | -2.8% |
| 2 months | $17.61 | +2.6% | $0.35 | $1,046 | +4.6% |
| 3 months | $17.34 | +4.2% | $0.35 | $1,062 | +6.2% |
| 6 months | $16.78 | +7.7% | $0.70 | $1,119 | +11.9% |
| 1 year | $14.74 | +22.6% | $1.41 | $1,322 | +32.2% |
| 2 years | $11.95 | +51.2% | $2.82 | $1,747 | +74.7% |
| 3 years | $9.73 | +85.8% | $4.22 | $2,292 | +129.2% |
| 5 years | $14.78 | +22.3% | $7.04 | $1,699 | +69.9% |
Historical returns from market close data. Past performance does not guarantee future results.